Planet 13 Holdings (PLNH) Asset Writedowns and Impairment (2021 - 2025)
Planet 13 Holdings' (PLNH) quarterly Asset Writedowns and Impairment came in at $11.7 million in Q4 2025, up 1284.67% year-on-year from $846449.0 in Q4 2024, and up 100.01% on a QoQ basis from $5.9 million in Q3 2025.
Planet 13 Holdings (PLNH) Asset Writedowns and Impairment (2021 - 2025) Analysis & Trends
Planet 13 Holdings (PLNH) has 5 years of Asset Writedowns and Impairment data on file, last reported at $11.7 million in Q4 2025.
- On a quarterly basis, Asset Writedowns and Impairment rose 1284.67% year-over-year to $11.7 million in Q4 2025; TTM through Dec 2025 was $20.1 million, a 59.33% decrease from a year earlier, with the FY2025 full-year figure at $17.6 million, up 442.69% from the prior year.
- Asset Writedowns and Impairment for Q4 2025 stood at $11.7 million, up from $5.9 million in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for PLNH reached as high as $46.8 million in Q4 2023 and fell as low as -$3.3 million in Q4 2021.
- Historically, Asset Writedowns and Impairment has averaged $5.7 million across 5 years, with a median of $950585.0 in 2022.
- Across the five-year window, Asset Writedowns and Impairment slumped 162.1% in 2022 and jumped 1284.67% in 2025, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at -$3.3 million in 2021, then surged by 308.46% to $6.9 million in 2022, then jumped by 574.27% to $46.8 million in 2023, then slumped by 98.19% to $846449.0 in 2024, then soared by 1284.67% to $11.7 million in 2025.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $11.7 million in Q4 2025, $5.9 million in Q3 2025, and $846449.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.47 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.56 Bn | 12.13 Bn | 785.00 Mn |
| 10 | Planet 13 Holdings | 38.53 Mn | 22.27 Mn | 9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.72 Mn |
| Dec 31, 2025 | 11.72 Mn |
| Sep 30, 2025 | 5.86 Mn |
| Sep 30, 2025 | 5.86 Mn |
| Dec 31, 2024 | 846,449.00 |
| Dec 31, 2024 | 846,449.00 |
| Sep 30, 2024 | 1.63 Mn |
| Sep 30, 2024 | 1.63 Mn |
| Dec 31, 2023 | 46.85 Mn |
| Dec 31, 2023 | 46.85 Mn |
| Dec 31, 2022 | 6.95 Mn |
| Dec 31, 2022 | 6.95 Mn |
| Sep 30, 2022 | -1.80 Mn |
| Sep 30, 2022 | -1.80 Mn |
| Jun 30, 2022 | 849,008.00 |
| Jun 30, 2022 | 849,008.00 |
| Mar 31, 2022 | 950,585.00 |
| Mar 31, 2022 | 950,585.00 |
| Dec 31, 2021 | -3.33 Mn |
| Dec 31, 2021 | -3.33 Mn |